Pinnacle Wealth Planning Services’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$79K	Buy	2,427 +201	+9%	+$6.46K	0.01%	935
2025 Q4	$78.3K	Buy	+2,226	New	+$78.9K	0.01%	922
2024 Q4	–	Sell	-6,507	Closed	-$412K	–	557
2024 Q3	$412K	Sell	6,507 -284	-4%	-$16.7K	0.06%	227
2024 Q2	$360K	Sell	6,791 -838	-11%	-$54.9K	0.05%	240
2024 Q1	$626K	Sell	7,629 -8,177	-52%	-$364K	0.09%	144
2023 Q4	$294K	Hold	15,806	–	–	0.05%	277
2023 Q3	$175K	Hold	15,806	–	–	0.03%	378
2023 Q2	$256K	Sell	15,806 -10,063	-39%	-$211K	0.04%	297
2023 Q1	$431K	Sell	25,869 -1,078	-4%	-$11.1K	0.07%	198
2022 Q4	$253K	Hold	26,947	–	–	0.05%	297
2022 Q3	$73K	Hold	26,947	–	–	0.01%	383
2022 Q2	$78K	Buy	+26,947	New	+$66.7K	0.01%	394